Overcoming Obstacles to LAI ART Implementation

Target Audience

The educational design of this activity addresses the needs of infectious disease and other HIV-treating physicians (MDs), nurse practitioners (NPs), physician associates (PAs), and pharmacists regarding long-acting injectable (LAI) antiretroviral therapy (ART).

Program Overview

The advent of LAI ART has changed the landscape of HIV treatment. LAI cabotegravir/rilpivirine (CAB/RPV) is approved for use in patients who are virally suppressed, though recent research has been conducted on its use in patients who are not suppressed. Particular care must be taken around adherence and discontinuation of LAI ART, as there are notable differences in protocols compared with oral ART. Despite its availability, many clinics still struggle to implement protocols and develop workflows that facilitate use of LAI ART. In this interactive activity designed to help clinicians overcome specific challenges in the context of patient cases, Dr. Aadia Rana will discuss patient selection, missed doses and adherence, LAI ART discontinuation, and practicalities of LAI ART implementation in the clinic.

Educational Objectives 

After completing this activity, the participant should be better able to:

• Identify patients eligible for treatment with a 2-drug LAI ART regimen
• Devise clinic protocols to streamline LAI ART implementation
• Address missed doses of LAI ART to avoid virologic failure or resistance
• Create and implement subsequent ART regimens for patients who are discontinuing LAI ART                

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Credit Statements

• Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
• For ABIM MOC points, your information will be shared with the ABIM through Integritas’ Program and Activity Reporting System (PARS). Please allow 6 to 8 weeks for your MOC points to appear in your ABIM records.
• By sharing your Diplomate Board ID number and date of birth, you are giving Integritas Communications permission to use this information/data to report your participation to these Boards via the PARS.

Nursing Continuing Education

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with commendation.

Credit Designation

Global Education Group designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-25-004-H02-P)

This is a knowledge-based activity.

Integritas Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.

Global Contact Information

For information about the accreditation (ANCC & ACPE credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:

1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
2. Complete the Preactivity Questions.
3. Review the activity content.
4. Achieve a grade of at least 70% on the Postactivity Test and complete the Evaluation.
5. Pharmacists must check the CPE Monitor for credits within 60 days of the activity. Credit for pharmacists cannot be issued after 60 days.

System Requirements

PC

1.4 GHz Intel Pentium 4 or faster processor (or equivalent)

Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)

512 MB of RAM (1 GB recommended)

Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome

For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 

MAC 

1.83 GHz Intel Core Duo or faster processor

512 MB of RAM (1 GB recommended)

MAC OS X 10.12, 10.13, and 10.14

Mozilla Firefox, Apple Safari, Google Chrome

For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) 

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Integritas Communications and Global Education Group (Global) adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  

All relevant financial relationships have been mitigated. 

The faculty have the following relevant financial relationships with ineligible companies:

Aadia Rana, MD, FIDSA: No financial relationships to report.

The planners and managers at Integritas Communications and Global Education Group have no relevant financial relationships to disclose. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.